The central cannabinoid receptor type-2 (CB2) and chronic pain

被引：29
|
作者：
Shang, Yuchao [1 ,2 ]
Tang, Yuying [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp 2, Dept Anesthesiol, Chengdu, Peoples R China
[2] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 2017年 / 127卷 / 09期
基金：
中国国家自然科学基金;
关键词：
Cannabinoid; CB2; pain; analgesia; clinical; RANDOMIZED CONTROLLED-TRIAL; CHRONIC NEUROPATHIC PAIN; INCREASES INTRACELLULAR CALCIUM; ACTIVATED PROTEIN-KINASE; SPINAL DORSAL-HORN; MULTIPLE-SCLEROSIS; GLIAL ACTIVATION; NERVE INJURY; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO;
D O I：
10.1080/00207454.2016.1257992
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Cannabinoid receptor type-2 (CB2, CB2 receptor or CB2-R) mediates analgesia via two mechanisms. CB2 receptors contained in peripheral immune tissue mediate analgesia by altering cytokine profiles, and thus have little adverse effects on central nervous systems (CNSs). CB2 is also expressed in the neurons and glial cells of the CNS. This neuronal expression may also contribute to pain attenuation. The CB2 receptor has been proposed as a potential target in treating chronic pain of several etiologies.
引用
收藏
页码：812 / 823
页数：12
相关论文
共 50 条
  • [11] Cannabichromene is a cannabinoid CB2 receptor agonist
    Udoh, Michael
    Santiago, Marina
    Devenish, Steven
    McGregor, Iain S.
    Connor, Mark
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (23) : 4537 - 4547
  • [12] Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
    Yamamoto, Wataru
    Mikami, Tadayoshi
    Iwamura, Hiroyuki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 583 (01) : 56 - 61
  • [13] Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
    Racz, Ildiko
    Nadal, Xavier
    Alferink, Judith
    Banos, Josep E.
    Rehnelt, Jennifer
    Martin, Miquel
    Pintado, Belen
    Gutierrez-Adan, Alfonso
    Sanguino, Elena
    Manzanares, Jorge
    Zimmer, Andreas
    Maldonado, Rafael
    JOURNAL OF NEUROSCIENCE, 2008, 28 (46): : 12125 - 12135
  • [14] Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain
    Maulik D. Jhaveri
    Devi R. Sagar
    Steven J. R. Elmes
    David A. Kendall
    Victoria Chapman
    Molecular Neurobiology, 2007, 36 : 26 - 35
  • [15] Formation of supramolecular structures of alkylamides from Echinacea -: implications for cannabinoid type-2 receptor (CB2) interactions in vitro
    Roduner, S.
    Bisson, W.
    Altmann, K. H.
    Gertsch, J.
    PLANTA MEDICA, 2006, 72 (11) : 1013 - 1013
  • [16] CB2 cannabinoid receptor agonists:: pain relief without psychoactive effects?
    Malan, TP
    Ibrahim, MM
    Lai, J
    Vanderah, TW
    Makriyannis, A
    Porreca, F
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) : 62 - 67
  • [17] Microglial Cannabinoid CB2 Receptors in Pain Modulation
    Xu, Kangtai
    Wu, Yifei
    Tian, Zhuangzhuang
    Xu, Yuanfan
    Wu, Chaoran
    Wang, Zilong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [18] Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain
    Jhaveri, Maulik D.
    Sagar, Devi R.
    Elmes, Steven J. R.
    Kendall, David A.
    Chapman, Victoria
    MOLECULAR NEUROBIOLOGY, 2007, 36 (01) : 26 - 35
  • [19] Chronic activation of the cannabinoid type 2 receptor (CB2) is neuroprotective in ischemic stroke by decreasing proinflamatory cytokines
    Zarruk, J. G.
    Fernandez-Lopez, D.
    Pradillo, J.
    Romera, V. G.
    Lizasoain, I.
    Moro, M. A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S512 - S513
  • [20] Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
    Poso, A.
    Huffman, J. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 335 - 346
12345